-
101
Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markers
Published 2025-01-01“…Breast Cancer Research…”
Get full text
Article -
102
Annotation-free deep learning algorithm trained on hematoxylin & eosin images predicts epithelial-to-mesenchymal transition phenotype and endocrine response in estrogen receptor-po...
Published 2025-01-01“…Breast Cancer Research…”
Get full text
Article -
103
Tumour DNA methylation markers associated with breast cancer survival: a replication study
Published 2025-01-01“…Breast Cancer Research…”
Get full text
Article -
104
Phase I trial of hydroxychloroquine to enhance palbociclib and letrozole efficacy in ER+/HER2− breast cancer
Published 2025-01-01“…npj Breast Cancer…”
Get full text
Article -
105
Effect of daily alcohol intake on sex hormone levels among postmenopausal breast cancer survivors on aromatase inhibitor therapy: a randomized controlled crossover pilot study
Published 2025-01-01“…Breast Cancer Research…”
Get full text
Article -
106
Prevalence, clinicopathologic features and long-term overall survival of early breast cancer patients eligible for adjuvant abemaciclib and/or ribociclib
Published 2025-02-01“…npj Breast Cancer…”
Get full text
Article -
107
Serum metabolomic profiling for predicting therapeutic response and toxicity in breast cancer neoadjuvant chemotherapy: a retrospective longitudinal study
Published 2025-01-01“…Breast Cancer Research…”
Get full text
Article -
108
G-cleave LC3B biosensor: monitoring autophagy and assessing resveratrol's synergistic impact on doxorubicin-induced apoptosis in breast cancer cells
Published 2024-12-01“…Breast Cancer Research…”
Get full text
Article -
109
Adjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/HER2– breast cancer (LEADER)
Published 2025-01-01“…npj Breast Cancer…”
Get full text
Article -
110
Exploring the role of ESR1 mutations in metastatic hormone receptor-positive breast cancer T cell immune surveillance disruption
Published 2025-02-01“…Breast Cancer Research…”
Get full text
Article -
111
Obesity increases DNA damage in the breast epithelium
Published 2025-01-01“…Breast Cancer Research…”
Get full text
Article -
112
Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypes
Published 2025-01-01“…npj Breast Cancer…”
Get full text
Article -
113
GRK6 palmitoylation dictates triple-negative breast cancer metastasis via recruiting the β-Arrestin 2/MAPKs/NF-κB signaling axis
Published 2024-12-01“…Breast Cancer Research…”
Get full text
Article -
114
Patient-derived response estimates from zero-passage organoids of luminal breast cancer
Published 2024-12-01“…Breast Cancer Research…”
Get full text
Article -
115
Triple-negative breast cancer modifies the systemic immune landscape and alters neutrophil functionality
Published 2025-01-01“…npj Breast Cancer…”
Get full text
Article -
116
Natural killer cells occupy unique spatial neighborhoods in HER2- and HER2+ human breast cancers
Published 2025-01-01“…Breast Cancer Research…”
Get full text
Article -
117
-
118
Evaluation of Long-Term Lymphedema Rate in Patients With Subclinical Lymphedema Diagnosed in the Preoperative Period via Bioimpedance
Published 2025-01-01“…European Journal of Breast Health…”
Get full text
Article -
119
High-Dose Toremifene as a Promising Candidate Therapy for Hormone Receptor-Positive Metastatic Breast Cancer with Secondary Resistance to Aromatase Inhibitors
Published 2020-01-01“…International Journal of Breast Cancer…”
Get full text
Article -
120
Immunotherapeutic Approaches in Triple-Negative Breast Cancer: State of the Art and Future Perspectives
Published 2020-01-01“…International Journal of Breast Cancer…”
Get full text
Article